Maine Coast Regional Health Facilities

Maine Coast Regional Health Facilities was paid $24.78M by Medicaid between Jan 2018 and Dec 2024, across 372 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 33% of everything it billed.

33Billing provider infoMAINE COAST REGIONAL HEALTH FACILITIES
ELLSWORTH, ME 04605

33aNPI1740249739assigned 03/20/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$24.78M

24GClaims774,171

24DCodes billed372

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Maine

Rank by total paid#9 of 33

Median peer was paid$4.34M

This provider vs. median5.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	112,034	$3.24M
2019	109,830	$3.29M
2020	106,586	$3.24M
2021	115,677	$3.83M
2022	115,392	$3.76M
2023	121,583	$3.94M
2024incomplete	93,069	$3.48M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	33%	112,355	87,121	$8.12M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	8.8%	7,019	6,291	$2.19M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	8.5%	11,248	9,941	$2.11M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	5.2%	11,446	10,337	$1.29M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	4.4%	37,948	35,325	$1.09M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	4.3%	26,669	24,988	$1.07M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	2.9%	7,166	6,222	$730K
97530	Therapeutic activities, direct patient contact, each 15 minutes	2.9%	12,579	4,543	$721K
74177	Computed tomography, abdomen and pelvis; with contrast material	1.9%	2,827	2,631	$468K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.8%	5,576	3,549	$447K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.4%	15,757	5,738	$347K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	1.1%	7,214	1,952	$265K

360 more codes

99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	1.0%	4,471	$251K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	4,415	$245K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	2,922	$231K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	2,474	$231K
70450	Computed tomography, head or brain; without contrast material	<1%	2,846	$226K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	10,621	$210K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	3,732	$208K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	3,075	$203K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	3,301	$193K
96375	Therapeutic injection; each additional sequential IV push	<1%	5,719	$186K
96361	Intravenous infusion, hydration; each additional hour	<1%	3,765	$152K
71046	Radiologic examination, chest; 2 views	<1%	3,743	$150K
97602		<1%	3,366	$146K
71045	Radiologic examination, chest; single view	<1%	4,034	$137K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	2,352	$134K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	2,202	$106K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	911	$93K
20610		<1%	868	$92K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	710	$70K
84443	Thyroid stimulating hormone (TSH)	<1%	10,285	$67K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	3,590	$63K
99203	Doctor's office visit, new patient (routine)	<1%	1,822	$62K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	6,255	$61K
80053	Comprehensive metabolic panel	<1%	29,181	$61K
80061	Lipid panel	<1%	8,148	$60K
97535	Self-care/home management training, each 15 minutes	<1%	2,859	$57K
G0008	Administration of influenza virus vaccine	<1%	2,955	$56K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	850	$55K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	3,559	$52K
76830	Ultrasound, transvaginal	<1%	644	$51K
99215	Doctor's office visit, returning patient (complex)	<1%	1,027	$51K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	12,583	$49K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	1,872	$47K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	84	$46K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	2,138	$44K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	781	$44K
99204	Doctor's office visit, new patient (more involved)	<1%	667	$43K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	3,466	$42K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	1,094	$41K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	29,234	$41K
86900		<1%	1,100	$40K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,943	$40K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	97	$39K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	2,624	$38K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	2,616	$38K
97803		<1%	1,430	$37K
97162		<1%	1,064	$34K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	98	$34K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	1,285	$33K
83036	Hemoglobin; glycosylated (A1C)	<1%	8,633	$31K
36415	Collection of venous blood by venipuncture	<1%	36,495	$30K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	2,518	$30K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	485	$30K
90472	Immunization administration, each additional vaccine (list separately)	<1%	4,542	$29K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	700	$28K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	506	$28K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	2,729	$28K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	87	$25K
Q3014	Telehealth originating site facility fee	<1%	1,814	$23K
G0009	Administration of pneumococcal vaccine	<1%	748	$23K
11721		<1%	2,646	$23K
97161		<1%	493	$21K
87510		<1%	2,052	$21K
87480		<1%	2,054	$20K
73610		<1%	1,327	$20K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	376	$20K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	9,907	$20K
99309	Subsequent nursing facility care, per day, low to moderate complexity	<1%	1,181	$20K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	1,931	$19K
87631		<1%	898	$19K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	1,145	$17K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	116	$17K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	1,157	$17K
99308	Subsequent nursing facility care, per day, straightforward	<1%	1,654	$16K
80050	General health panel	<1%	780	$16K
73562		<1%	1,415	$16K
90473		<1%	695	$16K
97163		<1%	551	$15K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	837	$15K
85027		<1%	7,161	$15K
71275	Computed tomographic angiography, chest, with contrast material	<1%	182	$15K
87430		<1%	2,992	$14K
73110		<1%	954	$14K
82728		<1%	2,863	$14K
82607		<1%	2,649	$14K
87086	Culture, bacterial; quantitative colony count, urine	<1%	7,551	$13K
76819	Fetal biophysical profile; without non-stress testing	<1%	141	$13K
90686		<1%	4,140	$12K
59025	Fetal non-stress test	<1%	91	$12K
83550		<1%	3,822	$12K
73030		<1%	1,072	$12K
94060		<1%	131	$12K
52000		<1%	54	$12K
80048	Basic metabolic panel (calcium, ionized)	<1%	7,922	$11K
73630		<1%	812	$10K
83540		<1%	4,134	$10K
83655		<1%	1,053	$10K
76642		<1%	176	$10K
84439		<1%	2,434	$9K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	336	$9K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	14	$9K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	421	$8K
87081		<1%	3,773	$8K
G0399	Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation	<1%	71	$8K
72100		<1%	270	$8K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	26	$8K
73502		<1%	970	$7K
96367		<1%	283	$6K
92504		<1%	2,817	$6K
93017		<1%	196	$6K
87660		<1%	374	$6K
85610		<1%	7,865	$6K
31575		<1%	72	$6K
97802		<1%	98	$6K
98927		<1%	455	$6K
83735		<1%	9,997	$6K
86140		<1%	4,575	$6K
81001		<1%	10,220	$6K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	54	$6K
84702		<1%	746	$6K
93971		<1%	91	$6K
86803		<1%	1,218	$5K
0002A		<1%	135	$5K
0054A		<1%	230	$5K
71250		<1%	102	$5K
97166		<1%	113	$4K
73130		<1%	582	$4K
87070		<1%	1,034	$4K
0001A		<1%	118	$4K
82570		<1%	2,830	$4K
87186		<1%	2,025	$4K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	41	$4K
36591		<1%	565	$4K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	209	$4K
86618		<1%	827	$4K
97116		<1%	379	$4K
99335		<1%	65	$4K
71271		<1%	58	$4K
84703		<1%	2,899	$3K
90620		<1%	85	$3K
95251		<1%	263	$3K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	70	$3K
76775		<1%	174	$3K
81003		<1%	6,827	$3K
G0433	Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening	<1%	322	$3K
84153		<1%	510	$3K
83880		<1%	2,045	$3K
87077		<1%	2,360	$2K
72125	Computed tomography, cervical spine; without contrast material	<1%	506	$2K
93271		<1%	40	$2K
85018		<1%	1,993	$2K
90480		<1%	299	$2K
82043		<1%	1,261	$2K
83970		<1%	191	$2K
85651		<1%	1,797	$2K
82746		<1%	418	$2K
73564		<1%	132	$2K
93225		<1%	38	$2K
91320		<1%	148	$2K
99442		<1%	82	$2K
74018		<1%	90	$2K
0134A		<1%	186	$2K
76801		<1%	17	$2K
99443		<1%	55	$2K
90677		<1%	15	$2K
77066	Tomosynthesis, mammo	<1%	30	$2K
83690		<1%	4,089	$1K
82950		<1%	344	$1K
97035		<1%	258	$1K
99307		<1%	123	$1K
80076		<1%	481	$1K
87280		<1%	1,638	$1K
87390		<1%	249	$1K
95806		<1%	59	$1K
85730		<1%	1,844	$1K
86038		<1%	226	$1K
95250		<1%	24	$1K
86592		<1%	310	$1K
81025		<1%	2,219	$1K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	13	$1K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	121	$1K
90670		<1%	947	$1K
87340		<1%	383	$989.52
85652		<1%	1,429	$979.17
96161		<1%	37	$930.50
87484		<1%	206	$921.04
87469		<1%	206	$921.02
96523		<1%	64	$912.80
76536		<1%	15	$911.23
90474		<1%	520	$887.04
84460		<1%	374	$858.25
99495		<1%	13	$857.83
99232	Hospital visit by a doctor, follow-up day	<1%	90	$811.08
86702		<1%	249	$795.46
97167		<1%	29	$788.60
87205		<1%	617	$742.97
84450		<1%	369	$726.58
90651		<1%	357	$693.45
99188		<1%	37	$684.00
86850		<1%	1,098	$669.14
93016		<1%	72	$659.95
86701		<1%	249	$659.73
90619		<1%	310	$632.70
76770		<1%	12	$614.12
76376		<1%	143	$600.80
87468		<1%	124	$590.51
86617		<1%	53	$588.62
82247		<1%	269	$580.32
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	12	$579.40
90662		<1%	417	$564.78
83516		<1%	75	$525.69
87040		<1%	1,172	$502.04
G0378	Hospital observation service, per hour	<1%	522	$500.00
99239	Hospital discharge day management, more than 30 minutes	<1%	43	$493.22
91322		<1%	38	$484.95
87478		<1%	137	$467.71
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	2,172	$453.84
93018		<1%	69	$420.95
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	2,392	$418.09
0072A		<1%	84	$411.26
00811		<1%	13	$402.75
84484		<1%	5,368	$391.42
D1206	Topical application of fluoride varnish	<1%	56	$384.00
82565		<1%	392	$382.99
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	1,777	$353.45
0064A		<1%	105	$341.99
00812		<1%	13	$334.83
76000		<1%	32	$329.73
0124A		<1%	17	$308.79
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	435	$292.75
90680		<1%	677	$277.22
82040		<1%	355	$276.81
81002		<1%	1,240	$269.98
85379		<1%	824	$267.62
84100		<1%	264	$262.99
51798		<1%	152	$261.22
84075		<1%	173	$250.92
99406		<1%	18	$241.88
0004A		<1%	186	$238.28
82550		<1%	318	$233.21
83605		<1%	2,041	$226.20
J7120	Ringers lactate infusion, up to 1000 cc	<1%	1,733	$221.98
77080		<1%	12	$220.00
82784		<1%	63	$212.80
86706		<1%	24	$159.85
90656		<1%	20	$156.47
73080		<1%	30	$154.66
90756		<1%	159	$148.52
80305		<1%	797	$144.86
86762		<1%	71	$143.90
0154A		<1%	14	$137.24
82947		<1%	43	$134.82
92551		<1%	13	$132.96
93272		<1%	12	$129.87
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	301	$127.68
J2704	Injection, propofol, 10 mg	<1%	3,477	$122.64
86376		<1%	13	$116.40
84146		<1%	14	$116.28
82150		<1%	143	$109.90
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	3,961	$109.78
0074A		<1%	16	$109.61
84156		<1%	98	$105.85
83525		<1%	13	$102.24
80299		<1%	14	$97.93
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	4,761	$94.24
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	15	$94.00
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	2,077	$91.32
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	1,922	$91.32
86431		<1%	28	$90.72
90715		<1%	851	$87.08
94727		<1%	39	$83.48
86901		<1%	1,121	$74.62
73140		<1%	14	$69.47
80178		<1%	28	$68.80
83721		<1%	26	$65.59
84466		<1%	12	$63.80
83615		<1%	38	$54.41
84550		<1%	66	$51.25
85378		<1%	255	$43.74
90648		<1%	182	$43.34
0071A		<1%	84	$43.00
84481		<1%	12	$40.73
94729		<1%	63	$39.64
82948		<1%	922	$31.24
82962		<1%	887	$31.07
99173		<1%	14	$27.02
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	303	$26.73
84520		<1%	22	$20.15
82248		<1%	18	$20.08
93270		<1%	42	$16.78
73620		<1%	57	$16.19
J7030	Infusion, normal saline solution , 1000 cc	<1%	4,696	$15.48
J7050	Infusion, normal saline solution, 250 cc	<1%	1,699	$12.18
96376		<1%	2,474	$8.14
82803		<1%	352	$8.06
85014		<1%	15	$4.74
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,379	$3.62
82077		<1%	158	$3.45
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	207	$3.25
90672		<1%	335	$1.52
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	1,479	$0.31
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	18	$0.04
90710		<1%	122	$0.03
90716		<1%	43	$0.03
J3475	Injection, magnesium sulfate, per 500 mg	0%	992	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	148	$0.00
J2270	Injection, morphine sulfate, up to 10 mg	0%	150	$0.00
90707		0%	55	$0.00
90633		0%	492	$0.00
90700		0%	54	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	171	$0.00
A9575	Injection, gadoterate meglumine, 0.1 ml	0%	126	$0.00
80179		0%	103	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	232	$0.00
90671		0%	182	$0.00
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	0%	162	$0.00
93226		0%	38	$0.00
J1050	Injection, medroxyprogesterone acetate, 1 mg	0%	460	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	150	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	12	$0.00
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	0%	71	$0.00
80143		0%	159	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	60	$0.00
80361		0%	27	$0.00
91300		0%	129	$0.00
C9113	Injection, pantoprazole sodium, per vial	0%	36	$0.00
90734		0%	145	$0.00
J1650	Injection, enoxaparin sodium, 10 mg	0%	27	$0.00
80348		0%	29	$0.00
94150		0%	25	$0.00
J1170	Injection, hydromorphone, up to 4 mg	0%	378	$0.00
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	0%	2,103	$0.00
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	0%	126	$0.00
J0131	Injection, acetaminophen, not otherwise specified,10 mg	0%	2,010	$0.00
90723		0%	456	$0.00
90696		0%	102	$0.00
A9270	Non-covered item or service	0%	1,146	$0.00
36416		0%	2,923	$0.00
J0696	Injection, ceftriaxone sodium, per 250 mg	0%	1,940	$0.00
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	0%	83	$0.00
J2060	Injection, lorazepam, 2 mg	0%	480	$0.00
J2765	Injection, metoclopramide hcl, up to 10 mg	0%	240	$0.00
90697		0%	294	$0.00
91307		0%	111	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	134	$0.00
Q2036	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)	0%	23	$0.00
88342		0%	50	$0.00
90647		0%	272	$0.00
88304		0%	52	$0.00
88300		0%	64	$0.00
C1773	Retrieval device, insertable (used to retrieve fractured medical devices)	0%	45	$0.00
91306		0%	127	$0.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	0%	197	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	48	$0.00
S0320	Telephone calls by a registered nurse to a disease management program member for monitoring purposes; per month	0%	18	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	12	$0.00
94760		0%	23	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	93	$0.00
94250		0%	14	$0.00
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	0%	40	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRONAN, JOHN (PRESIDENT)